BioCentury
ARTICLE | Company News

Celltech Group, J&J deal

January 29, 2001 8:00 AM UTC

The companies will discover, develop and commercialize orally active cancer compounds based on selective inhibitors of the enzyme KDR kinase, which plays a role in tumor vascularization. The parties w...